Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jean-Michel Rivet"'
Autor:
Staffan Schmidt, Joseph T. Coyle, Micaela Galante, Glenn Dallérac, Kevin C. F. Fone, Silvia Sacchi, Grégoire Levasseur, Jan Kehr, David J. G. Watson, Brigitte Potier, Xia Li, Pierre Lecouflet, Alain M. Gardier, Loredano Pollegioni, Thu Ha Pham, Rachel Asselot, Angelo Contarino, Pascal Fossat, Jean-Pierre Mothet, Millan Mark, Andrey Besedin, Ginetta Collo, Thomas Freret, Jean-Michel Rivet, Nadege Morisot
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (23), pp.e2023750118. ⟨10.1073/pnas.2023750118⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, ⟨10.1073/pnas.2023750118⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, 118 (23), pp.e2023750118. ⟨10.1073/pnas.2023750118⟩
Proc Natl Acad Sci U S A
Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (23), pp.e2023750118. ⟨10.1073/pnas.2023750118⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, ⟨10.1073/pnas.2023750118⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2021, 118 (23), pp.e2023750118. ⟨10.1073/pnas.2023750118⟩
Proc Natl Acad Sci U S A
International audience; Prefrontal control of cognitive functions critically depends upon glutamatergic transmission and N-methyl D-aspartate (NMDA) receptors, the activity of which is regulated by dopamine. Yet whether the NMDA receptor coagonist d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e3d40a1a9203362891908b7866e4c8
https://hal.archives-ouvertes.fr/hal-03277751
https://hal.archives-ouvertes.fr/hal-03277751
Publikováno v:
Journal of Psychopharmacology. 30:1099-1128
The highly-interconnected and neurochemically-rich frontal cortex plays a crucial role in the regulation of mood and cognition, domains disrupted in depression and other central nervous system disorders, and it is an important site of action for thei
Autor:
Millan Mark, Kevin C. F. Fone, Rodolphe Billiras, Alain P. Gobert, Anne Dekeyne, Jean-Michel Rivet, Dorothée Sicard, David J. G. Watson
Publikováno v:
Molecular Neurobiology
Frontocortical NMDA receptors are pivotal in regulating cognition and mood, are hypofunctional in schizophrenia, and may contribute to autistic spectrum disorders. Despite extensive interest in agents potentiating activity at the co-agonist glycine m
Autor:
Clotilde Mannoury la Cour, Denis Hervé, Jean-Antoine Girault, Millan Mark, Jean-Michel Rivet, Marie-Josèphe Salles, Sophie Longueville
Publikováno v:
Journal of Neurochemistry. 125:532-544
D2/D3 dopamine receptors (D2R/D3R) agonists regulate Akt, but their effects display a complex time-course. In addition, the respective roles of D2R and D3R are not defined and downstream targets remain poorly characterized, especially in vivo. These
Autor:
Brian P. Lockhart, Trevor Sharp, Jean-Pierre Galizzi, Marianne Rodriguez, Millan Mark, Florence Serres, Jean-Michel Rivet
Publikováno v:
Neuropharmacology. 63:992-1001
Studies of 5-HT-glutamate interactions suggest that activation of brain 5-HT(2A) receptors leads to an AMPA receptor-mediated induction of the immediate early (activity-dependent) gene, Arc (Arg3.1). In this respect, noradrenaline-glutamate interacti
Autor:
Joël Bockaert, Jean-Michel Rivet, Anne Dekeyne, Julie Meffre, Clotilde Mannoury la Cour, Philippe Marin, David J. G. Watson, Paul Déléris, Denis Hervé, Kevin C. F. Fone, Millan Mark, Florence Loiseau, Martial Séveno, Florence Gaven, Séverine Chaumont-Dubel
Publikováno v:
EMBO Molecular Medicine
Cognitive deficits in schizophrenia severely compromise quality of life and are poorly controlled by current antipsychotics. While 5-HT(6) receptor blockade holds special promise, molecular substrates underlying their control of cognition remain uncl
Autor:
Amélie Soumier, Trevor Sharp, Mariusz Papp, Mauricette Brocco, Gunnar Flik, Jean-Michel Rivet, Anne Dekeyne, Françoise Lejeune, Thomas I. F. H. Cremers, Alain Gobert, Florence Serres, Millan Mark, Annie Daszuta, Olivier Muller, Clotilde Mannoury la Cour, Gilbert Lavielle
Publikováno v:
Psychopharmacology (Berl)
Psychopharmacology (Berl), 2008, 199 (4), pp.549-68
Psychopharmacology (Berl), 2008, 199 (4), pp.549-68
RATIONALE: Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states. OBJECTIVES: Herein, we characterized the in vitro and in vivo pharmacological p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b939857ddaecc03e4bac8547193eef2
https://ora.ox.ac.uk/objects/uuid:bf9f3d5a-5050-4674-be0f-6a9c9f69b4b2
https://ora.ox.ac.uk/objects/uuid:bf9f3d5a-5050-4674-be0f-6a9c9f69b4b2
Autor:
Jean A. Boutin, P. Monika Verdouw, Marianne Rodriguez, Roberto Maggio, Philippe Vayer, Takashi Yoshitake, Gabriella Aloisi, Catherine de Montrion, Brian P. Lockhart, Mauricette Brocco, Jean-Michel Rivet, Per Svenningsson, Jean-Pierre Galizzi, Lotte De Groote, Benjamin Di Cara, Francis Cogé, Laetitia Cistarelli, Sylvie Veiga, Lucianne Groenink, Ebba Gregorsson Lundius, Millan Mark, Alain Gobert
Publikováno v:
The Journal of Neuroscience. 31:16928-16940
“Ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)] is of considerable interest in light of its prosocial properties and risks associated with widespread recreational use. Recently, it was found to bind trace amine-1 receptors (TA1Rs), which modu
Autor:
Gunnar Flik, Trynke R. de Jong, Millan Mark, Guillaume de Nanteuil, Anne Dekeyne, Clotilde Mannoury la Cour, Berend Olivier, Françoise Lejeune, Thomas I. F. H. Cremers, Mauricette Brocco, Jean-Michel Rivet, Alain Gobert, Benjamin Di Cara
Publikováno v:
European Neuropsychopharmacology. 20:599-621
Though neurokinin(1) (NK(1)) receptors are implicated in depressed states and their treatment, selective antagonists have disappointed in clinical trials. Accordingly, we designed a novel ligand, S41744 (2-piperazin-1-yl-indan-2-carboxylic-acid-(3-ch
Autor:
Rodolphe Billiras, Thomas I. F. H. Cremers, Mauricette Brocco, Jean-Michel Rivet, Gunnar Flik, Florence Loiseau, Anne Dekeyne, Dorothée Sicard, Millan Mark, Alain P. Gobert
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 324:1212-1226
In contrast to clinically available antipsychotics, the novel benzopyranopyrrolidine derivative, S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), behaves as a preferential antagonis